Even after symptom relief, regular follow-up remains necessary to monitor for disease recurrence or transformation.[19] Hormone therapy may be appropriate for inoperable or metastatic low-grade adenosarcoma that expresses estrogen and progesterone receptors. This evidence concerns the gene PGR and adenosarcoma.